Biosimilar drugs will soon be entering the breast cancer treatment landscape and are already available for support medications. With these emerging treatment options, it’s important to know more about them so you can make informed decisions about your treatment plan.

In complete contrast to constipation, diarrhea is also a common side effect of treatment. While many chemotherapies and targeted therapies cause constipation, some of the others cause diarrhea. Loss of bowel control can not only be embarrassing, but it can cause painful cramps and lead to dehydration.

Poop, definitely a topic that most of us don’t want to have candid conversations about, especially when it comes to our own. But constipation is one of the most common side effects of many cancer treatments, and can be a real pain in the a**, literally.

Clinical trials play a big role in the discovery of new treatments for cancer. They help to determine the safety and effectiveness of potential new treatments. For metastatic patients, they can also potentially offer additional treatment options after the cancer has grown resistant to the standards of care.

Here are some highlights from the latest in breast cancer research:

We’ve been talking a lot lately about side effects and ways to manage or cope with the many symptoms of cancer treatment. But what we haven’t talked about in all of these posts is how cannabis (or marijuana) can be used to help with your side effects. We thought it best to dedicate a blog post entirely on cannabis to help you better understand how it may help relieve your symptoms and how it’s regulated in Canada. 

My husband can spend hours washing and polishing his car. Hours. Seriously. A Sunday afternoon can go by, and he is outside working away. I used to feel resentful and irritated. Not anymore.

Triple Negative Breast Cancer Day is an annual global event on March 3. This is a day for a global awareness and grassroots fundraising aimed at helping to eradicate triple-negative breast cancer and celebrating the courage and strength of triple negative breast cancer patients and survivors.